Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
03/28/2000 | US6042821 Treating sepsis using chemokines which are a protein or polypeptide |
03/28/2000 | CA2164152C New compounds of the secomacrolide and secoazalide class and a process for the preparation thereof |
03/28/2000 | CA2140531C Method of increasing expression of viral proteins |
03/28/2000 | CA2063862C Topical preparation containing a suspension of solid lipid particles |
03/28/2000 | CA2014472C N-acyl derivatives of the ll-e33288 antitumor antibiotics |
03/28/2000 | CA2011238C Pharmaceutical treatment |
03/23/2000 | WO2000016231A1 Method for screening and producing compound libraries |
03/23/2000 | WO2000015853A1 Recombinant newcastle disease virus rna expression systems and vaccines |
03/23/2000 | WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
03/23/2000 | WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
03/23/2000 | WO2000015798A2 Mammalian transforming growth factor beta - 9 (ztgfss9) |
03/23/2000 | WO2000015793A2 Human gpcr proteins |
03/23/2000 | WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |
03/23/2000 | WO2000015775A1 Rnase p polypeptides |
03/23/2000 | WO2000015770A2 Human serine/threonine protein kinases |
03/23/2000 | WO2000015769A1 Topa |
03/23/2000 | WO2000015760A1 Streptococcal c beta protein compositions |
03/23/2000 | WO2000015659A2 Stomach polypeptide zsig28 |
03/23/2000 | WO2000015655A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
03/23/2000 | WO2000015640A1 Carbapenem compounds |
03/23/2000 | WO2000015634A2 Hiv protease inhibitors |
03/23/2000 | WO2000015609A1 Azetidine derivatives, preparation and medicines containing them |
03/23/2000 | WO2000015265A1 Compositions and methods of use of uptake mechanisms for diagnostic and therapeutic applications of oligonucleotides targeting bacteria |
03/23/2000 | WO2000015264A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
03/23/2000 | WO2000015263A1 Expandible microparticle intracellular delivery system |
03/23/2000 | WO2000015256A2 Immunostimulant emulsion |
03/23/2000 | WO2000015255A1 Vaccine against sexually transmitted diseases |
03/23/2000 | WO2000015251A2 Influenza virus vaccine composition |
03/23/2000 | WO2000015249A1 Treatment of kaposi's sarcoma with il-12 |
03/23/2000 | WO2000015244A2 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
03/23/2000 | WO2000015240A1 Anionic or cationic dendrimer antimicrobial or antiparasitic compositions |
03/23/2000 | WO2000015235A1 Method of using tetracycline compounds to enhance interleukin-10 production |
03/23/2000 | WO2000015232A1 Taurolidine and/or taurultam against infectious ulcer or gastritis |
03/23/2000 | WO2000015214A1 Fc RECEPTOR MODULATORS AND USES THEREOF |
03/23/2000 | WO2000015212A2 Antifungal activity of dicationic molecules |
03/23/2000 | WO2000015210A2 Use of mycophenol acid and its derivatives for the treatment of virus diseases |
03/23/2000 | WO2000015208A2 New use of immunosupressants for mmp-mediated diseases |
03/23/2000 | WO2000015202A2 Topical application products |
03/23/2000 | WO2000015198A1 Orally administered controlled drug delivery system providing temporal and spatial control |
03/23/2000 | WO2000015178A2 Computer implemented pharmacokinetics method and program |
03/23/2000 | WO2000015036A1 Topical dermal antimicrobial compositions |
03/23/2000 | WO1999066948A3 Use of a dipeptide for stimulating repair processes |
03/23/2000 | WO1999042588A3 Group b streptococcus antigens |
03/23/2000 | DE19842415A1 Pharmaceutical preparation for treating e.g. tumors, thrombosis or inflammation, contains cyclic pentapeptide integrin inhibitor and chemotherapeutic agent and/or angiogenesis inhibitor |
03/23/2000 | DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection |
03/23/2000 | CA2706859A1 Mammalian transforming growth factor beta - 9 |
03/23/2000 | CA2344445A1 Antifungal activity of dicationic molecules |
03/23/2000 | CA2344441A1 Expandible microparticle intracellular delivery system |
03/23/2000 | CA2344151A1 Pharmaceutical preparation |
03/23/2000 | CA2344036A1 Pharmacokinetic-based drug design tool and method |
03/23/2000 | CA2343914A1 Method for screening and producing compound libraries |
03/23/2000 | CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control |
03/23/2000 | CA2343578A1 Human serine/threonine protein kinases |
03/23/2000 | CA2343355A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
03/23/2000 | CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
03/23/2000 | CA2343051A1 Streptococcal c beta protein compositions |
03/23/2000 | CA2343001A1 Stomach polypeptide zsig28 |
03/23/2000 | CA2342833A1 Human gpcr proteins |
03/23/2000 | CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
03/23/2000 | CA2342395A1 Process for producing peptides from biological fluids and peptides obtainable by said process |
03/23/2000 | CA2342313A1 Immunostimulant emulsion |
03/23/2000 | CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors |
03/22/2000 | EP0987329A2 Multimeric form of human rhinovirus receptor protein |
03/22/2000 | EP0987267A1 Carbapenem compounds, use thereof, and intermediate compounds of the same |
03/22/2000 | EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid |
03/22/2000 | EP0987027A1 Physiologically active extract |
03/22/2000 | EP0986649A1 Retroviral vector particles produced in a baculovirus expression system |
03/22/2000 | EP0986646A1 Ubiquitin conjugation proteins |
03/22/2000 | EP0986577A2 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria |
03/22/2000 | EP0986570A1 Gemcitabine derivatives |
03/22/2000 | EP0986563A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones |
03/22/2000 | EP0986554A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability |
03/22/2000 | EP0986381A1 Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
03/22/2000 | EP0986375A2 Use of mkc-442 in combination with other antiviral agents |
03/22/2000 | EP0775114B1 Process for making antimicrobial compounds |
03/22/2000 | CN1248288A Nuclear trasfer with differentiated fetal and adult donor cells |
03/22/2000 | CN1248261A Novel erythromycin derivatives, method of preparation and application as medicines |
03/22/2000 | CN1248167A Administration of injectable antibiotic in ear of animal |
03/22/2000 | CN1248164A Antiviral agents |
03/22/2000 | CN1247747A Application of endive in preparing medicine for treating tuberculosis |
03/22/2000 | CN1050632C Productive Process and use of human anti-tumour alpha type interferon and mutant thereof |
03/22/2000 | CN1050631C Preparation for high efficiency anti-tumor gama-type interferon mutant and use thereof |
03/22/2000 | CN1050603C Prepn. of intermediate product used in process for diastereoselective synthesis of nucleosides |
03/21/2000 | US6040480 Preparing 2-(1,1,1-trifluoro-2-hydroxy-4-cyclopropyl-but-3-yn-2-yl),4-chloroaniline; cyclization; human immunodeficiency virus (hiv) reverse transcriptase inhibitor nontoxic maaterials; nonchromagraphic purification |
03/21/2000 | US6040447 Reacting a halogenated amino pyrimidine compound with acid anhydride or acid halide to form an intermediate, transforming the 6-halo group of the intermediate to an amine by displacement with ammonia, cyclizing with a base |
03/21/2000 | US6040435 Antimicrobial cationic peptides |
03/21/2000 | US6040346 Use of L-carnitine and derivatives for reducing ceramide levels and potentiating antiretroviral drugs |
03/21/2000 | US6040341 Compounds and their compositions having anti-inflammatory and anti-thrombotic activities |
03/21/2000 | US6040336 Treating bacterially induced meningitis |
03/21/2000 | US6040329 Substituted indazole analogs |
03/21/2000 | US6040328 Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
03/21/2000 | US6040321 Enzyme inhibitor treating cancer, inflammation and arthritis, neurodegenerative diseases such as alzheimer's disease, cardiovascular diseases, viral diseases and fungal diseases |
03/21/2000 | US6040319 cyclization; synthesis of cyclooxygenase-2 (COX) inhibitors such as etoricoxib |
03/21/2000 | US6040311 Treating bone disorders for preventing osteoporosis or inhibiting bone resorption in a mammal; treating tumor growth in a mammal |
03/21/2000 | US6040297 A therapeutic agents treating tumors and retroviral infections including hiv infections |
03/21/2000 | US6040291 Antimicrobial peptide |
03/21/2000 | US6040170 Human cytomegalovirus DNA sequences |
03/21/2000 | US6040167 Synthetic membrane vesicles containing functionally active fusion peptides as drug delivery systems |
03/21/2000 | US6040163 Amino acid sequence which couples asparagine to transfer rna; for screening bacteriostats and bactericides |
03/21/2000 | US6040162 Amino acid sequence which couples histidine to transfer rna; for screening bacteriostats and bactericides |